TAIBANG BIOLOGICAL GROUP
Taibang Biologic Group is a Chinese biopharmaceutical company that provides a comprehensive range of plasma-derived products. The company's core business includes the development, manufacture, and sale of plasma-derived products and other biopharmaceutical products.
TAIBANG BIOLOGICAL GROUP
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2002-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.en.chinabiologic.com
Total Employee:
1001+
Status:
Active
Contact:
+86-10-6598-3177
Total Funding:
899.55 M USD
Technology used in webpage:
SPF Euro Amazon DNSSEC Microsoft Azure DNS PHP Pound Sterling IIS 10 PHP 7 Japanese Yen
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Faron Pharmaceuticals
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Tonghua Shengjixin Biotechnology Co.Ltd
Tonghua Shengjixin Biotechnology Co.Ltd is a ginseng health products brand and pharmaceutical company.
Current Employees Featured
Joseph Chow Chairman and CEO @ Taibang Biological Group
Chairman and CEO
Ming Yang Chief Financial Officer @ Taibang Biological Group
Chief Financial Officer
Stock Details
Investors List
GIC
GIC investment in Private Equity Round - Taibang Biological Group
Cinda Securities
Cinda Securities investment in Private Equity Round - Taibang Biological Group
China Life Investment Holding
China Life Investment Holding investment in Private Equity Round - Taibang Biological Group
Abu Dhabi Investment Authority
Abu Dhabi Investment Authority investment in Private Equity Round - Taibang Biological Group
Centurium Capital
Centurium Capital investment in Post-IPO Equity - Taibang Biological Group
CITIC Capital Holdings
CITIC Capital Holdings investment in Post-IPO Equity - Taibang Biological Group
Hillhouse Investment
Hillhouse Investment investment in Post-IPO Equity - Taibang Biological Group
IDG Capital
IDG Capital investment in Post-IPO Equity - Taibang Biological Group
Official Site Inspections
http://www.en.chinabiologic.com
- Host name: 47.104.188.102
- IP address: 47.104.188.102
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
Cannot get whois informations of this domain!!!
More informations about "Taibang Biological Group"
TAIBANG BIOLOGIC GROUP
06/27 , 2023. Taibang Biological Ltd. - Notice of intention to continue as a company incorporated under the laws of the Cayman Islands. Taibang Biological Ltd., a company incorporated under the laws of the British Virgin Islands, is …See details»
About Us_TAIBANG BIOLOGIC GROUP - China Biologic Products
与地方政府及有影响力的民间组织合作开展多项慈善活动和公益项目，以提高社会对血友病的认识。 2016年4月，泰邦山东联合山东省扶贫办、山东省卫生计生委、山东省血液中心在山东省开 …See details»
泰邦生物集团
05/08 , 2025. 长顺单采血浆站正式投入运营 以合规安全为核心保障血浆质量. 2025年5月8日，泰邦生物集团旗下位于贵州省黔南州长顺县威远工业园区的长顺单采血浆站正式开业。See details»
China Biologic Products - Wikipedia
The company is engaged in the research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other healthcare facilities in China. Plasma-based human albumin is used mainly to increase blood volume while Immunoglobulin is used for disease prevention and treatment. Previously listed on Nasdaq, in April 2021, it was taken private in a $4.6 billion deal by an invest…See details»
Taibang Biological Group - Crunchbase Company Profile & Funding
Contact Email ir@chinabiologic.com Phone Number +86-10-6598-3177 Taibang Biologic Group is a Chinese biopharmaceutical company that provides a comprehensive range of plasma …See details»
China Biologic Products, Inc. - AnnualReports.com
China Biologic Products, Inc. (NASDAQ: CBPO) is a leading fully integrated plasma-based biopharmaceutical company in China. The Company's products are used as critical therapies during medical emergencies and for the …See details»
China Biologic Products - Company Profile & Staff Directory
China Biologic Products is a Medical company located in Beijing, Beijing with 1,000 employees. Access China Biologic Products's email format and China Biologic Products staff directory for …See details»
Taibang Biologic Group - CMOCRO - Domain Name
Taibang Biological Group is a leading comprehensive blood products biopharmeuceutical group in China. The core business of the group includes Research and development production and …See details»
Taibang Biologic Group - Craft
Taibang Biologic Group has 1 employees across 4 locations, $9.6 m in total funding, and $503.74 m in annual revenue in FY 2019. See insights on Taibang Biologic Group including office …See details»
关于我们_泰邦生物集团 - China Biologic Products
与地方政府及有影响力的民间组织合作开展多项慈善活动和公益项目，以提高社会对血友病的认识。 2016年4月，泰邦山东联合山东省扶贫办、山东省卫生计生委、山东省血液中心在山东省开展为期三年的“健康助力奔小康”健康扶贫公益活动 …See details»
Taibang Biologic Group - Overview, News & Similar companies
Nov 16, 2021 Who is Taibang Biologic Group. Founded in 2002, Taibang Bio Group is an advanced comprehensive blood products and biopharmaceutical enterprise. Its core business …See details»
China Biologic Products Holdings, Inc. - CMOCRO
China Biologic Products, Inc. is a China-based biopharmaceutical manufacturer dedicated to provide quality and safe plasma-based biopharmaceutical products that are used as critical …See details»
Contact us_TAIBANG BIOLOGIC GROUP - China Biologic Products
Headquarters. No.9-5,Jiangtai West Road,ChaoYang District, Beijing,100016,China. Shandong Manufacturing Base. No.5666, Longquan Road, Hi-Tech Zone, Tai'an City ...See details»
China Biologic Products Holdings Inc - Company Profile - GlobalData
Taibang Biologic Group (Taibang Biologic) formerly, China Biologic Products Holdings Inc, is a biopharmaceutical company that focuses on research and development, production, …See details»
R&D_TAIBANG BIOLOGIC GROUP - China Biologic Products
科技创新是公司发展的不竭动力。 集团自成立以来，注重科研投入和技术人才引进与培养，建立了一支30多人的高素质科研队伍，具有专业而高效的研发能力，先后承担多项国家、省、市级科 …See details»
China Biologic Products | CBPO Stock Price, Company Overview
Looking back to 2 days ago, China Biologic Products Inc (NASD: CBPO) priced a 3,870,000 share secondary stock offering at $110.00 per share. Buyers in that offering made a considerable …See details»
China Biologic Products Holdings, Inc. - 企查查
企查查为您提供China Biologic Products Holdings, Inc.的最新工商信息、公司简介、公司地址、电话号码、招聘信息、信用信息、财务信息、法律诉讼等多维度详细信息查询，让您对China …See details»
China Biologic Enters into Definitive Merger Agreement for Going ...
BEIJING, Nov. 19, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based …See details»
China Biologic Announces Completion of Going Private Transaction
BEIJING, April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based …See details»
China Biologic going-private transaction - Davis Polk
Davis Polk is advising the special committee of the board of directors of China Biologic Products Holdings, Inc. (“China Biologic”) in connection with the going-private acquisition of China …See details»